Imunon(IMNN) - 2022 Q4 - Annual Report
Imunon(IMNN)2023-03-30 12:21
COMMISSION FILE NO.: 001-15911 For the fiscal year ended December 31, 2022. or UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Washington, D.C. 20549 FORM 10-K (Mark One) For the transition period from _______ to _______ ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (State or other jurisdiction of incorporation or organization) | Title of each class | Trading Symbol(s) | Name ...